EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis

Andrea Ferrari iD, Daniel Orbach iD, Luca Bergamaschi iD, Reineke A Schoot, Max M van Noesel iD, Daniela Di Carlo iD, Gianni Bisogno iD, Rita Alaggio, Giuseppe Maria Milano iD, Stefano Chiaravalli, Fernando Fuccillo, Valerie Laurence und 5 weitere

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31038 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Andrea Ferrari und 16 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Sarcoma, Synovial, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose Though the prognosis for pediatric patients with localised synovial sarcoma (SS) is generally good, the chances of being cured after relapse are limited. This study describes a retrospective multi‐institutional series of relapsing SS patients treated at six selected European referral centers for pediatric sarcoma. Patients and methods The study included 41 patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, SynovialNeoplasm Recurrence, LocalHumansRetrospective StudiesMaleFemaleChildAdolescentChild, PreschoolPrognosisEuropeSurvival RateCombined Modality TherapyFollow-Up StudiesYoung AdultAdultInfant

Stichwörter der Autor:innen

adolescentschildrenoutcomeprognostic factors relapsesynovial sarcomatreatment

Autor:innen und Institutionen

  • Pediatric Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • SIREDO Oncology Center Care, (Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France.
  • Solid Tumors Department, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Division Imaging & Cancer, Pediatric Oncology Department, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Hematology Oncology Division, Department of Women's and Children's Health, University of Padua, Padua, Italy.
  • Department of Women's and Children's Health, University of Padua, Padua, Italy.

ORCID-Profile: Andrea Ferrari, Daniel Orbach, Luca Bergamaschi, Max M van Noesel, Daniela Di Carlo, Gianni Bisogno, Giuseppe Maria Milano, Patrizia Gasparini

Zitieren

APA

Ferrari, A., Orbach, D., Bergamaschi, L., Schoot, R. A., van Noesel, M. M., Di Carlo, D., Bisogno, G., Alaggio, R., Milano, G. M., Chiaravalli, S., Fuccillo, F., Laurence, V., Corradini, N., Gasparini, P., Vennarini, S., Pasquali, S., & Casanova, M. (2024). Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31038

Vancouver

Ferrari A, Orbach D, Bergamaschi L, Schoot RA, van Noesel MM, Di Carlo D, et al. Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31038

BibTeX
@article{Ferrari2024,
  author = {Ferrari, Andrea and Orbach, Daniel and Bergamaschi, Luca and Schoot, Reineke A and van Noesel, Max M and Di Carlo, Daniela and Bisogno, Gianni and Alaggio, Rita and Milano, Giuseppe Maria and Chiaravalli, Stefano and Fuccillo, Fernando and Laurence, Valerie and Corradini, Nadege and Gasparini, Patrizia and Vennarini, Sabina and Pasquali, Sandro and Casanova, Michela},
  title = {Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31038}
}
Kostenlos starten →